Clinical Trials Directory

Trials / Completed

CompletedNCT05811689

Trabecular Bone Score in Multiple Sclerosis

Trabecular Bone Score (TBS) as an Innovative Parameter Evaluation for Bone Disease's in Multiple Sclerosis (MS) Patients and Impact of Osteoporosis on the Quality of Life of Patients With MS

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Assess bone quality in MS patients through TBS and evaluate the potential effects exerted by different drugs used in MS treatment, which may affect BMD and TBS in MS patients

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTsm tbs groupAfter collecting anthropometric data, information on environmental factors and lifestyle (smoking, alcohol intake, physical activity, sun exposure, vitamin D supplementation, fish consumption) will be acquired through a questionnaire. The genetic and environmental aspects related to multiple sclerosis will also be studied. Disability status will be assessed through the Kurtzke Extended Disability Status Scale (EDSS). \[10\] All recruited patients will be administered the questionnaire (Multiple Sclerosis Quality of Life-54 (MSQOL-54) composed of 14 scales and 54 items. The scales investigate physical functions, limitations with respect to physical and emotional role, pain, emotional well-being, degree of energy, perceptions of one's health, social, cognitive and sexual functioning, distress, changes in health, satisfaction with sexual functioning and quality of life in general.

Timeline

Start date
2021-02-14
Primary completion
2021-08-20
Completion
2023-02-15
First posted
2023-04-13
Last updated
2023-04-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05811689. Inclusion in this directory is not an endorsement.